总部位于澳大利亚墨尔本的HealthGuard Corporation（非侵入性医疗保健的领导者）宣布，其HealthGuard AMIC / PLB已在广东省微生物检测中心使用活体冠状病毒进行了测试。

该公司声称，经过测试，将其HealthGuard AMIC / PLB抗病毒纺织品整理剂正确地应用于纤维和织物后，杀灭冠状病毒（H1N1）、SARS和流感病毒孢子的有效率达到99.9％，

HealthGuard产品只需要填充到散件上或喷涂到丝束中的纤维上，无需更改涂层，且已经过独立测试，洗涤50次后仍保持功效。该处理将应用于床上用品、床垫和枕头填充物，也将应用于游轮、飞机、火车、公共交通座椅、酒店软装家具、公共机构和老年护理设施。

HealthGuardPLB已在Oeko-Tex活性化学产品（ACP）清单上。该公司产品在澳大利亚政府批准的墨尔本许可制造厂生产。其最先进设施的日产能达100吨，还配有色母粒企业生产设施。

HealthGuard总裁Christopher Harvey博士表示，该公司产品有望在人类毒株COVID-19上获得令人满意的结果，该测试报告将很快发布。（编译：小轶 审校：小C）

原文：COVID-19:Positive test results for anti-viral textile finish imminent

Melbourne, Australia based HealthGuard Corporation, a leader innon-invasive healthcare, has announced that itsHealthGuardAMIC/PLBhas been tested usinglive Corona Virus at the Guang Dong Detection Centre of Microbiology. Thecompany claims that its HealthGuard AMIC/PLB anti-viral textile finish has beenindependently tested to be 99.9% effective against killing spores of CoronaVirus (H1N1), SARS and Influenza Virus when applied correctly to fibres andfabrics.

“We are expecting excellent results on Human Strain COVID-19. Thattesting report will be available very soon,” Dr Christopher Harvey, Presidentof HealthGuard, toldInnovation in Textiles.

“HealthGuard products are easily applied by padding onto piecegoods or spraying onto fibre in the tow. No changes in finishing need to bemade,” Dr Harvey added.

“HealthGuard AMIC/PLB has been independently tested to be durableup to 50 wash cycles whilst retaining efficacy.”

“We foresee the application of HealthGuard AMIC/PLB treatment onall bedding, mattresses and pillow fillings, to be used on cruise ships,aeroplanes, trains, public transport seating, all hotel soft furnishings,public institutions and aged care facilities.”

HealthGuard PLB is Oeko-Tex Active Chemical Products (ACP) listed.The company’s products are manufactured in Melbourne at its AustralianGovernment approved licenced manufacturing plant. Its state of the artsfacility provides for 100 tons of capacity per day, coupled with a masterbatchenterprise manufacturing facility.

HealthGuard Corporation Pty. Ltd. was founded in 1990 specificallyas a Research and Development arm of Global Specialty Chemicals Pty. Ltd. Bothcompanies are privately held within the Harvey family group.

“The initial success of the HealthGuard Corporation Pty. Ltd. wasour triple action anti-dust mite and anti-bacterial/fungal treatment fortextiles,” Dr Harvey explains. “When this HealthGuard treatment is applied tomattress tickings, PU Foam and PES fibres used in the construction ofmattresses, pillows fillings and duvets, the dust mite colony reduced by 99.9%.Therefore, no House Dust Mites (HDM) pathogens were created, which are knowntriggers for asthma attacks to 70% of all asthma sufferers.”

“We still enjoy receiving testimonials from clients who buy beds,bedding, furniture upholstered with HealthGuard treated fabrics.”

More products soon followed, with triple action anti-mosquito andanti-bacterial/fungal treatments for clothing, camping gear and outdooradventure clothing. HealthGuard was also first to market with anti-microbialtreatments for textiles which inhibited the growth of superbugs such as MRSAand VRE, a treatment which is used on many hospital gowns worldwide.